A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure

Authors: Thomas Ward, Ruth D. Lewis, Tray Brown, Garth Baxter, Antonio Ramirez de Arellano

Source: BMC Nephrology, Vol 24, Iss 1, Pp 1-15 (2023)

Subject Terms: Hyperkalaemia, RAASi, Patiromer, Chronic kidney disease, Heart failure, Cost-effectiveness, Diseases of the genitourinary system. Urology, RC870-923

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2369

Access URL: https://doaj.org/article/ef2bf1a535d040729b10560de1e96fea